Mitigating Usability Risks in Medical Device Development, in the light of the upcoming National Medical Product Administration (NMPA) guidelines in China.Read More
At PDD we like to keep one eye on the horizon, scanning themes and emerging trends across the healthcare sector to understand what’s next. As the rise of digital health and therapeutics continues, we take a look at what this means for the patient experience and what opportunities lie in the area of self-care and self-management.Read More
PDD and Tri-Star Design announced today a new partnership that will accelerate innovation, design and development for a rapidly expanding digital healthcare market.Read More
PDD launches new initiative to put medics at the heart of innovation.
We are delighted to announce the appointment of Dr Jim Roberts, consultant anaesthetist and medical innovator at University College London Hospitals (UCLH), as an independent advisor in healthcare innovation. This initiative seeks to transform how medical technology is developed and used in hospital settings by putting medics at the heart of the process.Read More
Over the past year, health has become the focal point of our lives in a way that few of us could have predicted, nor ignored. Just like consumer culture transformed our societies two centuries ago, health and health-related issues now shape our identity, our lifestyle, our perspectives and importantly our aspirations for the future.
In this article, Emma Dickinson – Consultant, Research Recruitment at PDD, explores people’s evolving attitudes in healthcare and how healthcare providers, pharmaceutical companies and medical device manufacturers can make the most of that opportunity to deliver a compelling, engaging experience for all.Read More
We are delighted to see the Zephyr Plus Ventilator recognised with the C2I award for COVID-19 Response by The Engineer magazine.
Led by Babcock International Group in response to the UK Government’s ventilator challenge in the early days of the pandemic, this was a highly collaborative project where PDD and over 50 partners and suppliers worked together to find the most appropriate solution.
Ergonomics and Human Factors practice are inherently broad and multi-disciplinary, but one thing that unites us all is a focus on design.Read More
Techniques such as AI and Machine Learning are creating new opportunities for healthcare and changing the way that people interact with health services.Read More
We are pleased to let you know that this autumn we will be present at some of the most prestigious medical events in China.Read More
The PDD team was asked to produce a system that is both reliable and user-friendly and within a branding format that is suitable for a wide range of medical and industrial-commercial settingsRead More
Conducting any kind of patient-centric evaluation can present numerous challenges; preparing for and conducting evaluation sessions with patients suffering from sensitive and changeable conditions (such as Alzheimer’s) can present even more complex challenges, as we found out on a study we conducted in the past year.Read More
Following our successful transition in June to the latest 2016 revision of ISO13485, we were certified in November for a further 3 years for our client services in research, design, engineering, pre-production manufacture, verification and validation.Read More
PDD has completed its planned transition to the latest version of this rigorous international quality assurance standard for medical devices, building on the success of earlier transitions and successful audits to the FDA 21CFR Part 820 in 2015.Read More
An extract taken from Chris Vincent’s knowledge piece that discusses the growing use of digital platforms such as social media to understand how people really use medical products.Read More
The consumer goods sector (FMCG, apparel, automotive, electronics) has always had greater freedom to explore design research in comparison to the Pharma industry, which is significantly more restricted. One of the problems with a stricter and more constrained set of rules is that it can curb innovation by creating limitations in the approach Pharma companies take during the development process and justification for when Patient Centred Design comes into debate. Often regulatory walls can slow the development of a new products and services and directly affect the time taken to introduce a new product to market.Read More
In my recent blog post on patient-centricity, I highlighted that the pharma industry has over the past years embarked on a journey towards more patient-centricity and that this trend actually has broad support across key players. At the same time, even with the best of intentions, it will take time for this new ethos to be truly embedded in the business practices of all pharma companies.Read More